Literature DB >> 8622947

Characterization of a second secreted IgE isoform and identification of an asymmetric pathway of IgE assembly.

F D Batista1, D G Efremov, O R Burrone.   

Abstract

A number of alternatively spliced epsilon transcripts have been detected in IgE-producing B cells, in addition to the mRNAs encoding the classical membrane and secreted IgE heavy (H) chains. In a recent study, we examined the protein products of three of these alternatively spliced isoforms and found that they are intracellularly retained and degraded because of their inability to assemble into complete IgE molecules. We have now similarly examined a more recently described epsilon mRNA species that is generated by splicing between a donor splice site immediately upstream of the stop codon in the H-chain constant region exon 4 (CH4) and an acceptor site located in the 3' part of the second membrane exon. We show that this isoform is efficiently secreted by both plasma cells and B lymphocytes and therefore represents a second secreted IgE isoform (epsilon S2). The epsilon S2 H chain is only six amino acids longer than the classical secreted Ig H chain (epsilon S1) and contains a C-terminal cysteine, which is a characteristic sequence feature of mu and alpha H chains. However, unlike IgM and IgA, the epsilon S2 C-terminal cysteine (Cys-554) does not induce polymerization of H2L2 molecules (where L is light chain), but rather creates a disulfide bond between the two H chains that increases the rate of association into covalently bound H2L2 monomers. This C-terminal cysteine also does not function as an intracellular retention element because the epsilon S2 isoform was secreted in amounts equal to that of the epsilon S1, both in B lymphocytes and in plasma cells. The epsilon S2 H chains secreted by B lymphocytes differed from the epsilon S1 H chains in the extent of glycosylation. Interestingly, a difference in glycosylation between B-lymphocytes and plasma cells was also noted for both isoforms. The presence of the Cys-554 also allowed the identification of a distinctive asymmetric pathway of IgE assembly, common to both types of epsilon H chains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622947      PMCID: PMC39620          DOI: 10.1073/pnas.93.8.3399

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms.

Authors:  D Diaz-Sanchez; A R Dotson; H Takenaka; A Saxon
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

2.  The efficiency of cysteine-mediated intracellular retention determines the differential fate of secretory IgA and IgM in B and plasma cells.

Authors:  S Guenzi; A M Fra; A Sparvoli; P Bet; M Rocco; R Sitia
Journal:  Eur J Immunol       Date:  1994-10       Impact factor: 5.532

3.  Complex alternative RNA splicing of epsilon-immunoglobulin transcripts produces mRNAs encoding four potential secreted protein isoforms.

Authors:  K Zhang; E E Max; H K Cheah; A Saxon
Journal:  J Biol Chem       Date:  1994-01-07       Impact factor: 5.157

4.  Characterization of four novel epsilon chain mRNA and a comparative analysis of genes for immunoglobulin E in rodents and man.

Authors:  L Hellman
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

5.  Heterogeneous IgE glycoforms characterized by differential recognition of an endogenous lectin (IgE-binding protein).

Authors:  M W Robertson; F T Liu
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

6.  Two unusual forms of human immunoglobulin E encoded by alternative RNA splicing of epsilon heavy chain membrane exons.

Authors:  K Zhang; A Saxon; E E Max
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

7.  Regulation of membrane IgM expression in secretory B cells: translational and post-translational events.

Authors:  R Sitia; M S Neuberger; C Milstein
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

8.  Quality control of ER synthesized proteins: an exposed thiol group as a three-way switch mediating assembly, retention and degradation.

Authors:  A M Fra; C Fagioli; D Finazzi; R Sitia; C M Alberini
Journal:  EMBO J       Date:  1993-12       Impact factor: 11.598

9.  Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac-2/epsilon BP) of the S-type lectin family: role in IgE-dependent activation.

Authors:  M J Truong; V Gruart; J P Kusnierz; J P Papin; S Loiseau; A Capron; M Capron
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

10.  Human keratinocytes release the endogenous beta-galactoside-binding soluble lectin immunoglobulin E (IgE-binding protein) which binds to Langerhans cells where it modulates their binding capacity for IgE glycoforms.

Authors:  A Wollenberg; H de la Salle; D Hanau; F T Liu; T Bieber
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

View more
  4 in total

1.  The two membrane isoforms of human IgE assemble into functionally distinct B cell antigen receptors.

Authors:  F D Batista; S Anand; G Presani; D G Efremov; O R Burrone
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

Review 2.  B Cell Intrinsic Mechanisms Constraining IgE Memory.

Authors:  Brice Laffleur; Orianne Debeaupuis; Zeinab Dalloul; Michel Cogné
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

3.  An antibody derivative expressed from viral vectors passively immunizes pigs against transmissible gastroenteritis virus infection when supplied orally in crude plant extracts.

Authors:  Wendy Monger; Josefa M Alamillo; Isabel Sola; Yolande Perrin; Marco Bestagno; Oscar R Burrone; Patricia Sabella; Joan Plana-Duran; Luis Enjuanes; Juan A Garcia; George P Lomonossoff
Journal:  Plant Biotechnol J       Date:  2006-11       Impact factor: 9.803

4.  IgE-tailpiece associates with α-1-antitrypsin (A1AT) to protect IgE from proteolysis without compromising its ability to interact with FcεRI.

Authors:  Phyllis M Quinn; David W Dunne; Shona C Moore; Richard J Pleass
Journal:  Sci Rep       Date:  2016-02-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.